1. Home
  2. NRDY vs ADCT Comparison

NRDY vs ADCT Comparison

Compare NRDY & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRDY
  • ADCT
  • Stock Information
  • Founded
  • NRDY 2007
  • ADCT 2011
  • Country
  • NRDY United States
  • ADCT Switzerland
  • Employees
  • NRDY N/A
  • ADCT N/A
  • Industry
  • NRDY Computer Software: Prepackaged Software
  • ADCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRDY Technology
  • ADCT Health Care
  • Exchange
  • NRDY Nasdaq
  • ADCT Nasdaq
  • Market Cap
  • NRDY 206.0M
  • ADCT 241.0M
  • IPO Year
  • NRDY N/A
  • ADCT 2020
  • Fundamental
  • Price
  • NRDY $1.69
  • ADCT $3.28
  • Analyst Decision
  • NRDY Hold
  • ADCT Strong Buy
  • Analyst Count
  • NRDY 8
  • ADCT 6
  • Target Price
  • NRDY $1.90
  • ADCT $7.80
  • AVG Volume (30 Days)
  • NRDY 516.0K
  • ADCT 733.2K
  • Earning Date
  • NRDY 08-07-2025
  • ADCT 08-05-2025
  • Dividend Yield
  • NRDY N/A
  • ADCT N/A
  • EPS Growth
  • NRDY N/A
  • ADCT N/A
  • EPS
  • NRDY N/A
  • ADCT N/A
  • Revenue
  • NRDY $184,099,000.00
  • ADCT $75,817,000.00
  • Revenue This Year
  • NRDY $4.60
  • ADCT $11.75
  • Revenue Next Year
  • NRDY $9.97
  • ADCT $10.29
  • P/E Ratio
  • NRDY N/A
  • ADCT N/A
  • Revenue Growth
  • NRDY N/A
  • ADCT 10.49
  • 52 Week Low
  • NRDY $0.73
  • ADCT $1.05
  • 52 Week High
  • NRDY $2.18
  • ADCT $3.98
  • Technical
  • Relative Strength Index (RSI)
  • NRDY 56.00
  • ADCT 57.96
  • Support Level
  • NRDY $1.52
  • ADCT $2.98
  • Resistance Level
  • NRDY $1.74
  • ADCT $3.19
  • Average True Range (ATR)
  • NRDY 0.06
  • ADCT 0.22
  • MACD
  • NRDY 0.01
  • ADCT 0.01
  • Stochastic Oscillator
  • NRDY 77.78
  • ADCT 84.63

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: